AEHR Turns a Corner: Revenue and Earnings Rise on New Test System and Analyst Upgrade

Forward-Looking Analysis

Analysts expect Aehr Test Systems to report revenue of approximately $11.5 million in 2026Q3, reflecting a year-over-year increase and a sequential improvement from Q2 2026’s $9.88 million. The consensus EPS estimate stands at $0.02, a significant turnaround from a loss of $0.11 in the prior quarter. While net income is projected to remain in the black at around $0.06 per share, this marks an improvement from the net loss in the previous quarter. Notably, JMP Securities upgraded AEHR to Market Outperform with a price target of $35, citing strong order growth and improved visibility in the semiconductor test equipment sector. No major downgrades were reported, though earnings estimates remain subject to near-term macroeconomic risks.

Historical Performance Review

In 2026Q2, Aehr Test Systems reported revenue of $9.88 million and a net loss of $3.23 million, or $0.11 per share. Gross profit for the quarter was $2.54 million. The results reflect ongoing cost pressures and underutilized production capacity, but improved sequential order trends signaled a potential turnaround.

Additional News

Aehr Test Systems announced the launch of a next-generation wafer-level test system in early March 2026, designed to support advanced packaging and 3D IC technologies. The product is expected to be available in Q3 2026 and positions the company to compete more effectively in high-growth segments of the semiconductor industry. Additionally, the company’s CEO participated in the SEMICON West 2026 panel, reiterating confidence in the long-term test equipment market. No M&A activity or major personnel changes were reported during the period.

Summary & Outlook

Aehr Test Systems is showing signs of a positive inflection in its business trajectory, with improving revenue trends and product innovation. The projected $11.5 million revenue and $0.02 EPS for 2026Q3 represent meaningful improvement from Q2’s $9.88 million and $0.11 loss. Gross profit has also stabilized at $2.54 million. The launch of a new test system and upgraded analyst ratings suggest a bullish outlook for near-term performance, though macroeconomic headwinds may temper expectations. On balance, AEHR’s strategic product development and stronger order momentum indicate a constructive setup for 2026Q3 and beyond.